When the M1 and M2 macrophages on the tumor sections (including the tumor islets and stroma) were counted under high-power fields, approximately 70% of macrophages were CD68+/CD163+ M2 macrophages and the remaining 30% of them were CD68+/HLA-DR+ M1 macrophages. The gene discussed is CD163; the disease is neoplasm.